{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T12:12:09Z","timestamp":1781957529333,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.cancergencyto.2010.02.005","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T04:29:54Z","timestamp":1273811394000},"page":"89-95","source":"Crossref","is-referenced-by-count":19,"title":["Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells"],"prefix":"10.1016","volume":"199","author":[{"given":"Nina","family":"Larsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Billstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Lilljebj\u00f6rn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Ekblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoas","family":"Fioretos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.02.005_bib1","series-title":"Cancer cytogenetics","first-page":"179","article-title":"Chronic myeloid leukemia","author":"Fioretos","year":"2009"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1\u2013positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"IRIS investigators. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib5","article-title":"Chromosomal abnormalities in Philadelphia (Ph)-negative cells of patients with chronic myeloide leukemia treated with imatinib (STI571)","volume":"88","author":"Besalduch","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib6","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.22699","article-title":"Characterization of Ph-negative abnormal clones emerging during imatinib therapy","volume":"109","author":"Abruzzese","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/10428190801975543","article-title":"Novel chromosomal aberration in Philadelphia negative cells of a patient with chronic myelogenous leukemia treated with dasatinib","volume":"49","author":"Athanasiadou","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.leu.2403607","article-title":"Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha","volume":"19","author":"Bacher","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal cytogenetic abnormalities in Ph\u2212 cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib10","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/cncr.22936","article-title":"The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells","volume":"110","author":"Deininger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib11","first-page":"556","article-title":"Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate","volume":"90","author":"Espinet","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib12","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","article-title":"Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"110","author":"Jabbour","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib13","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","article-title":"Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia","volume":"108","author":"Kovitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cancergencyto.2006.04.012","article-title":"Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors","volume":"170","author":"Lin","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib15","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cncr.11729","article-title":"Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase","volume":"98","author":"Medina","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ajh.20859","article-title":"Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome","volume":"82","author":"Navarro","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.leu.2402848","article-title":"Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate","volume":"17","author":"O'Dwyer","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2004.05215.x","article-title":"Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance?","volume":"127","author":"O'Shea","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib19","first-page":"90","article-title":"Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate","author":"Perel","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib20","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","article-title":"Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia","volume":"18","author":"Terre","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cancergencyto.2006.12.011","article-title":"Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case","volume":"176","author":"Zeidan","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib22","series-title":"ISCN 2009: an international system for human cytogenetic nomenclature","year":"2009"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/gcc.20442","article-title":"Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome","volume":"46","author":"Agerstam","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia; a Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib25","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3324\/haematol.11064","article-title":"Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure","volume":"92","author":"Fabarius","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0002-9343(96)00061-7","article-title":"Chronic myelogenous leukemia: a review","volume":"100","author":"Cortes","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib28","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/sj.onc.1203878","article-title":"Regulation of cell death by the Abl tyrosine kinase","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib29","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.leukres.2009.04.012","article-title":"Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST","volume":"33","author":"Pitini","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2141.2008.07104.x","article-title":"Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia","volume":"141","author":"Koike","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib31","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/sj.onc.1210361","article-title":"Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11","volume":"26","author":"Flotho","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2006-05-021162","article-title":"Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.005_bib33","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/sj.leu.2404796","article-title":"CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine","volume":"21","author":"Raj","year":"2007","journal-title":"Leukemia"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:59:56Z","timestamp":1544489996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0165460810000592"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.02.005","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}